share_log

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, ANVS and ATIP

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, ANVS and ATIP

克莱因律师事务所提醒投资者注意代表CCIV、ANVS和ATIP的股东提起集体诉讼
Accesswire ·  2021/08/28 23:45

NEW YORK, NY / ACCESSWIRE / August 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

纽约州纽约/ACCESSWIRE /2021 年 8 月 29 日/ 克莱因律师事务所宣布,已代表以下公司的股东提起集体诉讼。参加该套装不收取任何费用。 如果你蒙受了损失,你必须在首席原告的最后期限之前要求法院任命你为首席原告。

Churchill Capital Corp IV (NYSE:CCIV) 
Class Period: January 11, 2021 - February 22, 2021
Lead Plaintiff Deadline: August 30, 2021

丘吉尔资本第四公司(纽约证券交易所代码:CCIV) 
上课时间: 2021年1月11日-2021年2月22日
首席原告截止日期: 2021年8月30日

The complaint alleges that throughout the class period Churchill Capital Corp IV made materially false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

投诉称,在整个集体诉讼期间,丘吉尔资本公司四世作出了重大虚假和/或误导性陈述和/或未能披露:(1)Lucid 没有准备在 2021 年春季交付汽车;(2) Lucid 预计在 2021 年将生产 557 辆汽车,而不是与丘吉尔合并前吹捧的 6,000 辆汽车;(3) 鉴于上述情况,被告对公司的正面陈述业务、运营和潜在客户存在重大误导和/或缺乏合理依据。当真实细节进入市场时,诉讼声称投资者遭受了损失。

Learn about your recoverable losses in CCIV : http://www.kleinstocklaw.com/pslra-1/churchill-capital-corp-iv-loss-submission-form?id=19082&from=1

在 CCIV 中了解您的可追回损失 : http://www.kleinstocklaw.com/pslra-1/churchill-capital-corp-iv-loss-submission-form?id=19082&from=1

Annovis Bio, Inc. (NYSE American:ANVS) 
Class Period: May 21, 2021 - July 28, 2021
Lead Plaintiff Deadline: October 18, 2021

Annovis Bio, Inc.(纽约证券交易所美国股票代码:ANVS) 
上课时间: 2021年5月21日-2021年7月28日
首席原告截止日期: 2021年10月18日

The ANVS lawsuit alleges that Annovis Bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

ANVS诉讼称,Annovis Bio, Inc.作出了重大虚假和/或误导性陈述和/或未能披露:(1)Annovis的 ANVS401(Posiphen)是一种口服药物,据称可抑制作为神经变性主要原因的神经毒性蛋白的合成,但在方向、判断和问题解决等因素方面,没有在两个患者群体中显示出具有统计学意义的结果;以及(2)综上所述,被告对公司业务、运营的正面陈述以及潜在客户存在重大误导和/或缺乏合理的依据。

Learn about your recoverable losses in ANVS : https://www.kleinstocklaw.com/pslra-1/annovis-bio-inc-loss-submission-form?id=19082&from=1

了解您在 ANVS 中可收回的损失 : https://www.kleinstocklaw.com/pslra-1/annovis-bio-inc-loss-submission-form?id=19082&from=1

ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II (NYSE:ATIP) 
This lawsuit is on behalf of investors who: (a) purchased or otherwise acquired ATI securities between April 1, 2021 and July 23, 2021, inclusive and/or (b) held FVAC Class A common stock as of May 24, 2021 and were eligible to vote at FVAC's June 15, 2021 special meeting.
Lead Plaintiff Deadline: October 15, 2021

ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Cor 
本诉讼代表以下投资者:(a)在2021年4月1日至2021年7月23日期间(包括在内)购买或以其他方式收购了ATI证券和/或(b)截至2021年5月24日持有FVAC A类普通股并有资格在FVAC的2021年6月15日特别会议上投票。
首席原告截止日期: 2021年10月15日

The complaint alleges that throughout the class period ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II made materially false and/or misleading statements and/or failed to disclose that: (1) ATI was experiencing attrition among its physical therapists; (2) ATI faced increasing competition for clinicians in the labor market; (3) as a result of the foregoing, the Company faced difficulties retaining therapists and incurred increased labor costs; (4) as a result of the labor shortage, the Company would open fewer new clinics; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

该投诉称,在整个集体诉讼期间,ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II 作出了重大虚假和/或误导性陈述和/或未能披露:(1) ATI 在劳动力市场面临日益激烈的临床医生竞争;(3) 由于上述原因,公司在留住治疗师方面面临困难,劳动力成本增加;(4) 由于由于劳动力短缺,公司将减少开设的新诊所;(5) 因此在上述情况中,被告对公司业务、运营和前景的正面陈述具有重大误导性和/或缺乏合理的依据。

Learn about your recoverable losses in ATIP : https://www.kleinstocklaw.com/pslra-1/ati-physical-therapy-inc-f-k-a-fortress-value-acquisition-corp-ii-loss-submission-form?id=19082&from=1

在 ATIP 中了解您的可收回损失 : https://www.kleinstocklaw.com/pslra-1/ati-physical-therapy-inc-f-k-a-fortress-value-acquisition-corp-ii-loss-submission-form?id=19082&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

您无需担任首席原告即可参与任何赔偿。如果您在上课期间蒙受损失并希望获得更多信息,请致电 212-616-4899 与 J. Klein, Esq. 联系,或访问提供的网页。

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

J. Klein,Esq. 代表投资者并参与全国范围内涉及金融欺诈的证券诉讼。律师广告。先前的结果并不能保证类似的结果。

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com 
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

联系人:
J. Klein,Esq
帝国大厦
第五大道 350 号
第 59 层
纽约州纽约 10118
jk@kleinstocklaw.com
电话:(212) 616-4899
传真:(347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

来源: 克莱因律师事务所


View source version on accesswire.com:
在 accesswire.com 上查看源代码版本:

https://www.accesswire.com/661847/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-CCIV-ANVS-and-ATIP
https://www.accesswire.com/661847/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-CCIV-ANVS-and-ATIP

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发